Should I buy Keurig Dr Pepper (KDP) stock or is it too late?

Keurig Dr Pepper · Consumer Staples · price $32

See the full Keurig Dr Pepper (KDP) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Evercore ISI Group — 69% of its targets hit on this sector (124 calls tested). It aims for $32 (+0.4 %), call made on August 8, 2026, maturing on August 8, 2027 (20 d ago).

The 5 reliable analysts $38+19 %

The 5 other firms $37+16 %

How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $38 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Keurig Dr Pepper

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Jefferies	80 %	+8.4 %	5	$32 +0%
Morgan Stanley	83 %	+1.8 %	6	$40 +25%
Barclays	52 %	-2.4 %	23	$38 +19%
RBC Capital	43 %	-3.3 %	7	$42 +32%
UBS	33 %	-5.7 %	6	$39 +22%
JP Morgan	22 %	-8.2 %	9	$38 +19%
Wells Fargo	14 %	-11.4 %	7	$37 +16%

In short — Should you invest in Keurig Dr Pepper? Is it too late, still worth it? Analysts are fairly positive (70% buy, median target $38, i.e. +18%), and the most reliable on KDP targets even higher. But the valuation is stretched (P/E ~33). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

70% of analysts rate it a buy (Buy consensus, 10 ratings) — a sign of market conviction.
Median price target $38, i.e. +18% from the current price ($32).
The most reliable firm on KDP, Bernstein (100% hit rate, 2 scored calls), targets $38 (call made on June 12, 2026, maturing on June 12, 2027) (+19%) in its most recent call, and $38 (call made on June 11, 2026, maturing on June 11, 2027) (+19%) in the one coming due soonest.
Pays a dividend (2.8% yield), raised for 5 years — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 10 ratings, 3 are neutral.
High valuation (P/E ~33): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on KDP

Median target $38 (+18%) · 10 ratings · Buy consensus

Strong Buy00%

Buy770%

Hold330%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Keurig Dr Pepper now?

We won't decide for you. The facts: 70% of analysts rate it a buy, median target $38 (+18%), and Bernstein (most reliable on KDP, 100%) targets $38. Weigh that against valuation (P/E ~33). This is not personalized advice.

Is it too late to invest in Keurig Dr Pepper?

Not according to analysts: the median target ($38) is still +18% above the current price ($32) (most reliable on KDP: Bernstein, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Keurig Dr Pepper still worth investing in?

It depends on the gap between the price ($32) and its estimated value: analysts target $38 on median (+18%), with 70% buys (most reliable on KDP: Bernstein, 100%). Cross-check with their real reliability on KDP and the cautions above. Information, not advice.

What's the main risk in buying KDP?

The consensus is not unanimous: of 10 ratings, 3 are neutral.

→ Go deeper: the full Keurig Dr Pepper profile (consensus, analyst reliability, price target, performance).